Inventor · disambiguated record
Ashish Anilrao Dubewar
Also filed as: DUBEWAR ASHISH ANILRAO
12 granted patents·8 pending applications·4 citations·filing 2018–2025
85Inventor score
Top patents by PatentIndex Score
20 records- 0189US12263176B2Pharmaceutical liquid compositions of meloxicamSLAYBACK PHARMA LLC·Filed 2023·Granted Apr 1, 2025·1 cites·14 claims
- 0289US11872305B2Stable pharmaceutical compositions of succinylcholine chlorideSLAYBACK PHARMA LLC·Filed 2022·Granted Jan 16, 2024·2 cites·13 claims
- 0388US12133912B2Stable pharmaceutical compositions of succinylcholine chlorideSLAYBACK PHARMA LLC·Filed 2023·Granted Nov 5, 2024·1 cites·1 claims
- 0486US12151020B2Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateSLAYBACK PHARMA LLC·Filed 2024·Granted Nov 26, 2024·0 cites·14 claims
- 0583US2025375373A1Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateAZURITY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0682US11938217B2Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateSLAYBACK PHARMA LLC·Filed 2023·Granted Mar 26, 2024·0 cites·19 claims
- 0779US12370190B2Stable liquid compositions of netupitant and palonosetronSLAYBACK PHARMA LLC·Filed 2024·Granted Jul 29, 2025·0 cites·18 claims
- 0875US12383491B2Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateAZURITY PHARMACEUTICALS INC·Filed 2021·Granted Aug 12, 2025·0 cites·17 claims
- 0974US12097197B2Stable liquid compositions of netupitant and palonosetronSLAYBACK PHARMA LLC·Filed 2022·Granted Sep 24, 2024·0 cites·24 claims
- 1073US11793719B2Perfusion dosage formSUN PHARMACEUTICAL IND LTD·Filed 2022·Granted Oct 24, 2023·0 cites·16 claims
- 1172US2025312337A1Stable liquid compositions of netupitant and palonosetronAZURITY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1271US11110054B2Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateSLAYBACK PHARMA LLC·Filed 2018·Granted Sep 7, 2021·0 cites·10 claims
- 1371US10456354B1Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateSLAYBACK PHARMA LLC·Filed 2018·Granted Oct 29, 2019·0 cites·21 claims
- 1469US2023086729A1Stable pharmaceutical compositions of succinylcholine chlorideSLAYBACK PHARMA LLC·Filed 2022·Application pending·0 cites
- 1567US2022249507A1Pharmaceutical liquid compositions of meloxicamSLAYBACK PHARMA LLC·Filed 2022·Application pending·0 cites
- 1665US2025195535A1Pharmaceutical liquid compositions of meloxicamSLAYBACK PHARMA LLC·Filed 2025·Application pending·0 cites
- 1762US2024156829A1Stable Antiemetic Emulsions for Parenteral AdministrationSLAYBACK PHARMA LLC·Filed 2023·Application pending·0 cites
- 1854US2019046398A1Perfusion dosage formSUN PHARMACEUTICAL IND LTD·Filed 2018·Application pending·0 cites
- 1951US2022008337A1Pharmaceutical liquid compositions of meloxicamSLAYBACK PHARMA LLC·Filed 2021·Application pending·0 cites
- 2047US11040008B2Pharmaceutical compositions of meloxicamSLAYBACK PHARMA LLC·Filed 2019·Granted Jun 22, 2021·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Ashish Anilrao Dubewar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →